Keyphrases
Breast Cancer Progression
100%
Isocitrate Dehydrogenase 1 (IDH1)
100%
Metabolic Vulnerability
100%
Serine Biosynthesis
100%
PHGDH
55%
Tumor
22%
Metabolic Phenotype
22%
Triple-negative Breast Cancer
22%
PSAT1
22%
Genome-scale Metabolic Model
11%
Overexpression
11%
Antioxidant System
11%
Vulnerability
11%
Clinical Significance
11%
Cell Proliferation
11%
Glycolysis
11%
Functional Assay
11%
Human Epidermal Growth Factor Receptor 2 (HER2)
11%
Long-term Survival
11%
Cancer Research
11%
Mass Spectrometry
11%
Anchorage-independent Growth
11%
Promising Target
11%
Mitochondrial Respiration
11%
Cancer-specific
11%
Breast Cancer Subtypes
11%
Lethal Activity
11%
Oncogenic Role
11%
Mitochondria-targeted Antioxidants
11%
Phosphoserine Aminotransferase
11%
CRISPR-Cas9 Knockout
11%
Medicine and Dentistry
Breast Cancer
100%
Cancer Growth
100%
Serine
100%
Isocitrate Dehydrogenase 2
100%
Phosphoglycerate Dehydrogenase
55%
Malignant Neoplasm
22%
Neoplasm
22%
Triple Negative Breast Cancer
22%
In Vitro
11%
Antioxidant
11%
Carcinogenesis
11%
Cell Proliferation
11%
Clinical Significance
11%
Anchorage Independent Growth
11%
Oxidoreductase Inhibitor
11%
Clustered Regularly Interspaced Short Palindromic Repeat
11%
Protein Synthesis
11%
Mass Spectrum
11%
Cancer Research
11%
Transaminase
11%
Mitochondrial Respiration
11%
Cas9
11%
Phosphoserine
11%
Pharmacology, Toxicology and Pharmaceutical Science
Breast Cancer
100%
Cancer Growth
100%
Serine
100%
Isocitrate Dehydrogenase 2
100%
Phosphoglycerate Dehydrogenase
55%
Malignant Neoplasm
33%
Neoplasm
22%
Triple Negative Breast Cancer
22%
Lethal Dose
22%
Antioxidant
11%
Carcinogenesis
11%
Aminotransferase
11%
Phosphoserine
11%
Oxidoreductase Inhibitor
11%
Biochemistry, Genetics and Molecular Biology
Anabolism
100%
Isocitrate Dehydrogenase
100%
Serine
100%
Phosphoglycerate Dehydrogenase
55%
Lethal Dose
22%
Protein Biosynthesis
11%
Carcinogenesis
11%
Mass Spectrometry
11%
Cell Proliferation
11%
Transaminase
11%
Anchorage Independent Growth
11%
CRISPR/Cas9
11%
Mitochondrial Respiration
11%
Phosphoserine
11%